These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35268604)

  • 21. Synthesis of new 3-phenylquinazolin-4(3H)-one derivatives as potent antibacterial agents effective against methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA).
    Gatadi S; Gour J; Kaul G; Shukla M; Dasgupta A; Akunuri R; Tripathi R; Madhavi YV; Chopra S; Nanduri S
    Bioorg Chem; 2018 Dec; 81():175-183. PubMed ID: 30130650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, Molecular Docking Studies and Antibacterial Activities of Novel Monocationic Indole-benzimidazole Derivatives.
    Ates-Alagoz Z; Kisla MM; Goker H; Yildiz S
    Med Chem; 2021; 17(7):699-706. PubMed ID: 32310051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nadifloxacin: a quinolone for topical treatment of skin infections and potential for systemic use of its active isomer, WCK 771.
    Jacobs MR; Appelbaum PC
    Expert Opin Pharmacother; 2006 Oct; 7(14):1957-66. PubMed ID: 17020421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3-Hydroxy-1,5-dihydro-2H-pyrrol-2-ones as novel antibacterial scaffolds against methicillin-resistant Staphylococcus aureus.
    Cusumano AQ; Pierce JG
    Bioorg Med Chem Lett; 2018 Sep; 28(16):2732-2735. PubMed ID: 29525221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel benzyl phenyl sulfide derivatives as antibacterial agents against methicillin-resistant Staphylococcus aureus.
    Lu K; Chen Q; Xu XF; Meng Y; Lin J; Chen WM
    J Antibiot (Tokyo); 2020 Feb; 73(2):82-90. PubMed ID: 31723217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of eight fluoroquinolones against both methicillin-susceptible and -resistant Staphylococcus aureus isolated from skin infections.
    Nishijima S; Namura S; Akamatsu H; Kawai S; Asada Y; Kawabata S; Fujita M
    J Dermatol; 1995 Feb; 22(2):153-5. PubMed ID: 7722093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
    Alharthi S; Ziora ZM; Moyle PM
    Bioorg Med Chem; 2021 Dec; 52():116527. PubMed ID: 34839159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-thiadiazole-4-hydroxy-2-quinolone-3-carboxamides bearing heteroaromatic rings as novel antibacterial agents: Design, synthesis, biological evaluation and target identification.
    Xue W; Li X; Ma G; Zhang H; Chen Y; Kirchmair J; Xia J; Wu S
    Eur J Med Chem; 2020 Feb; 188():112022. PubMed ID: 31901744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and antibacterial activity of chalcones against MSSA and MRSA planktonic cells and biofilms.
    Garcia MAR; Theodoro RS; Sardi JCO; Santos MB; Ayusso GM; Pavan FR; Costa AR; Santa Cruz LM; Rosalen PL; Regasini LO
    Bioorg Chem; 2021 Nov; 116():105279. PubMed ID: 34509799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marinopyrrole derivatives as potential antibiotic agents against methicillin-resistant Staphylococcus aureus (II).
    Cheng C; Liu Y; Song H; Pan L; Li J; Qin Y; Li R
    Mar Drugs; 2013 Aug; 11(8):2927-48. PubMed ID: 23955285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antistaphylococcal activities of the new fluoroquinolone JNJ-Q2.
    Morrow BJ; Abbanat D; Baum EZ; Crespo-Carbone SM; Davies TA; He W; Shang W; Queenan AM; Lynch AS
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5512-21. PubMed ID: 21911562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and in vitro antibacterial activity of a series of novel gatifloxacin derivatives.
    Chai Y; Liu ML; Lv K; Feng LS; Li SJ; Sun LY; Wang S; Guo HY
    Eur J Med Chem; 2011 Sep; 46(9):4267-73. PubMed ID: 21764484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and in vitro antibacterial activity of novel fluoroquinolone derivatives containing substituted piperidines.
    Chai Y; Liu M; Wang B; You X; Feng L; Zhang Y; Cao J; Guo H
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5195-8. PubMed ID: 20667731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel fluoroquinolones analogues bearing 4-(arylcarbamoyl)benzyl: design, synthesis, and antibacterial evaluation.
    Peytam F; Norouzbahari M; Saadattalab T; Şanlıtürk G; Firoozpour L; Emamgholipour Z; Dogaheh MG; Nikou M; Tehrani MB; Bijanzadeh HR; Güran M; Foroumadi A
    Mol Divers; 2024 Jun; 28(3):1577-1596. PubMed ID: 37420079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methicillin-resistant Staphylococcus aureus (MRSA)-active metabolites from Platanus occidentalis (American Sycamore).
    Ibrahim MA; Mansoor AA; Gross A; Ashfaq MK; Jacob M; Khan SI; Hamann MT
    J Nat Prod; 2009 Dec; 72(12):2141-4. PubMed ID: 19904995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic Gram-positive bacteria isolated from bacterial skin infections.
    Nenoff P; Haustein UF; Hittel N
    Chemotherapy; 2004 Oct; 50(4):196-201. PubMed ID: 15452398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galloylated flavonol rhamnosides from the leaves of Calliandra tergemina with antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).
    Chan EW; Gray AI; Igoli JO; Lee SM; Goh JK
    Phytochemistry; 2014 Nov; 107():148-54. PubMed ID: 25174555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study.
    Kuok CF; Hoi SO; Hoi CF; Chan CH; Fong IH; Ngok CK; Meng LR; Fong P
    Exp Biol Med (Maywood); 2017 Apr; 242(7):731-743. PubMed ID: 28118725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cleistochlamys kirkii chemical constituents: Antibacterial activity and synergistic effects against resistant Staphylococcus aureus strains.
    Pereira F; Madureira AM; Sancha S; Mulhovo S; Luo X; Duarte A; Ferreira MJ
    J Ethnopharmacol; 2016 Feb; 178():180-7. PubMed ID: 26674158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial activity of ozenoxacin and other antimicrobials against Staphylococcus aureus strains isolated from clinical skin specimens in Japan in 2019 and 2020.
    Kurokawa I; Kanayama S; Yamasaki O
    J Infect Chemother; 2022 Dec; 28(12):1693-1696. PubMed ID: 35988886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.